{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glycine-encephalopathy-2","columns":[{"gene":"","key":"population-5dae49749b1fb8832b81","label":"Glycine encephalopathy 2","mondoId":"MONDO:0958192","onsetQualifier":null,"originColumnKey":"MONDO:0958192/OMIM:620398","originalViews":[{"key":"MONDO:0958192/OMIM:620398","label":"Glycine encephalopathy 2","scopeLabel":"OMIM:620398","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["131be41af58c54291ecb6d4d12a33f45175eb1af6190ce689ab1a0b17392804d","199b19e708c4b09917f71d9036424dec4cc0f60ba7323f564fd264c0b5a40cf4","240dd07785dd5f68882cbdff78a96e144edbbe3c675de7faf9dec83fa27bb0f6","2d8e03ad8c33171d848bc4590d6d0461ede385aefec1c7301990c07fe9f9cefc","69d16ceb67976ab90afbdf7c3522d48aa233258dda2f3b8dad25aeb71fb16f7b","da7701762184e68d21636195c50723ba407e6ff888383aec8190290d496c092e","e3c87ad861e85eb9786702204a93f7686e3a3227a16de72a74f05293f967db67"],"recordQualifiers":{},"scopeLabel":"OMIM:620398","sourceIds":["OMIM:620398"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-5dae49749b1fb8832b81"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0010851","HP:0500230","HP:0011342","HP:0008288","HP:0002878","HP:0001250","HP:0010864"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"published":7}},"features":[{"hpoId":"HP:0010851","label":"EEG with burst suppression","primary":true},{"hpoId":"HP:0500230","label":"Increased CSF glycine concentration","primary":true},{"hpoId":"HP:0011342","label":"Mild global developmental delay","primary":true},{"hpoId":"HP:0008288","label":"Nonketotic hyperglycinemia","primary":true},{"hpoId":"HP:0002878","label":"Respiratory failure","primary":true},{"hpoId":"HP:0001250","label":"Seizure","primary":true},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":true}],"ledeHtml":"","mondoId":"MONDO:0958192","node":{"canonicalSlug":"glycine-encephalopathy-2","comparisons":[{"documentSha256":"2bc9afd3b06ef211ddfbbd9f3cce7200f01b90949a9df9b7b77c4ea83db1763c","key":"legacy-nonketotic-hyperglycinemia","kind":"legacy","label":"glycine encephalopathy","memberIds":["MONDO:0011612","MONDO:0015010","MONDO:0958179","MONDO:0958192"],"mondoId":"MONDO:0011612","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/nonketotic-hyperglycinemia.2bc9afd3b06ef211ddfbbd9f3cce7200f01b90949a9df9b7b77c4ea83db1763c.json"},{"documentSha256":"8a31bf3a85654b6c56a7db08df7a0b5c5922c9de69f7e77f70ab867d8aef4db2","key":"expanded-nonketotic-hyperglycinemia","kind":"expanded","label":"glycine encephalopathy","memberIds":["MONDO:0011612","MONDO:0015010","MONDO:0017353","MONDO:0017354","MONDO:0957382","MONDO:0958179","MONDO:0958192"],"mondoId":"MONDO:0011612","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-8a31bf3a85654b6c56a7.8a31bf3a85654b6c56a7db08df7a0b5c5922c9de69f7e77f70ab867d8aef4db2.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-5dae49749b1fb8832b81"],"publication":"published","relationships":[{"kind":"parent","label":"glycine encephalopathy","mondoId":"MONDO:0011612","slug":"nonketotic-hyperglycinemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26967"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"131be41af58c54291ecb6d4d12a33f45175eb1af6190ce689ab1a0b17392804d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0011342","is_excluded":false,"label":"Mild global developmental delay","onset_id":null,"reference":"PMID:8005589","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"199b19e708c4b09917f71d9036424dec4cc0f60ba7323f564fd264c0b5a40cf4","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0002878","is_excluded":false,"label":"Respiratory failure","onset_id":"HP:0003623","reference":"PMID:9600239","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"240dd07785dd5f68882cbdff78a96e144edbbe3c675de7faf9dec83fa27bb0f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"PMID:8005589","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2d8e03ad8c33171d848bc4590d6d0461ede385aefec1c7301990c07fe9f9cefc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":"HP:0003623","reference":"PMID:9600239","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"69d16ceb67976ab90afbdf7c3522d48aa233258dda2f3b8dad25aeb71fb16f7b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0500230","is_excluded":false,"label":"Increased CSF glycine concentration","onset_id":null,"reference":"PMID:9600239","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"da7701762184e68d21636195c50723ba407e6ff888383aec8190290d496c092e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"16/16","hpo_id":"HP:0008288","is_excluded":false,"label":"Nonketotic hyperglycinemia","onset_id":null,"reference":"PMID:8005589;PMID:9600239","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e3c87ad861e85eb9786702204a93f7686e3a3227a16de72a74f05293f967db67","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:620398","disease_name":"Glycine encephalopathy 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0010851","is_excluded":false,"label":"EEG with burst suppression","onset_id":null,"reference":"PMID:9600239","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"glycine-encephalopathy-2","sourceDocuments":[],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"glycine encephalopathy 2"},"schemaVersion":1}
